LabCyte Wins $1M SBIR Grant to Continue Work with Stanford on MALDI-MS Protein Assays | GenomeWeb

Sample prep firm Labcyte said this week that it has received a $1 million Phase II small business innovation research grant for work on developing the company's acoustic liquid handling system as part of MALDI mass spec workflows.

The award, which follows a $196,000 Phase I SBIR grant the company received in November 2011, will fund a collaboration between Labcyte and researchers at Stanford University and the Fred Hutchinson Cancer Research Center exploring the use of MALDI mass spec for verification and validation of breast cancer biomarkers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.